SCHEMBL9609414

SCHEMBL9609414

Cn1c2ccc(Cl)cc2c(=O)c2cc([S+](c3ccc(O)cc3)c3ccc(O)cc3)ccc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK8 P45983 7/20 0.39
▸ MAPK9 P45984 5/20 0.39
▸ BAZ2B Q9UIF8 1/20 0.38
▸ MAPK10 P53779 4/20 0.38
▸ WEE1 P30291 2/20 0.38
▸ GABRA1 P14867 1/20 0.38
▸ GABRG2 P18507 1/20 0.38
▸ GABRB3 P28472 1/20 0.38
▸ GABRA5 P31644 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ KDM4E B2RXH2 3/20 0.37
▸ CHEK1 O14757 1/20 0.37
▸ GSK3B P49841 2/20 0.36
▸ DYRK3 O43781 1/20 0.36
▸ PIM1 P11309 1/20 0.36
▸ DYRK1A Q13627 1/20 0.36
▸ NTRK3 Q16288 1/20 0.36
▸ PIM3 Q86V86 1/20 0.36
▸ SRPK1 Q96SB4 1/20 0.36
▸ CLK4 Q9HAZ1 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9609395 0.85 HTT (0.48) KMT2AKDM4EALDH1A1HPGDHSD17B10
SCHEMBL9609407 0.82 RET (0.47) KMT2AKDM4EALDH1A1HPGDTSHR
SCHEMBL9609402 0.79 RXFP1 (0.43) KMT2AKDM4EALDH1A1HPGDHSD17B10
SCHEMBL13899688 0.77 MAPK8 (0.46) MAPK8MAPK9BAZ2BMAPK10GABRA1
SCHEMBL9609398 0.77 ALKBH5 (0.44) KMT2AKDM4EALDH1A1HPGDHSD17B10
SCHEMBL14050151 0.74 BCHE (0.56) BAZ2BWEE1KDM4ECHEK1CASP1
SCHEMBL13296002 0.73 ATM (0.57) KMT2AKDM4ECASP1ALDH1A1HPGD
SCHEMBL9609428 0.71 ATM (0.62) KMT2AKDM4EALDH1A1HPGDHSD17B10
SCHEMBL9609400 0.71 ALDH1A1 (0.59) KMT2AKDM4EALDH1A1HPGDHSD17B10
SCHEMBL9609397 0.70 ATM (0.50) KMT2AKDM4EALDH1A1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9073854-B2 Aromatic sulfonium salt compound ADEKA CORPORATION (JP) 2015-07-07 — — US disclosed
US-20120136155-A1 AROMATIC SULFONIUM SALT COMPOUND ADEKA CORPORATION (JP) 2012-05-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120136155-A1 AROMATIC SULFONIUM SALT COMPOUND F12, ASIC1, SPIN1 MAPK8 1218/4885MAPK9 1242/4885BAZ2B 2282/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback